8:00 am - 4:30 pm
Registration & Exhibits Open
Whether you're checking in, stopping by for conference information, or connecting with NANETS staff, the Registration Desk is here to help. While you're there, visit our industry partners located throughout the prefunction space and explore the latest innovations supporting the NET community.
8:00am – 9:00 am
Satellite Symposium: Supported by Novartis
Begin your day with an industry-supported educational symposium presented by Novartis. Breakfast will be served during the session. Alternatively, attendees are invited to enjoy breakfast while browsing the Poster Hall and engaging with presenting authors.
9:05 am – 10:20 am
Discover the latest advances in neuroendocrine tumor research during this featured oral abstract session. Selected from the highest-rated abstract submissions, these presentations highlight innovative scientific discoveries, clinical research, and emerging data that are shaping the future of NET care. Each presentation is followed by opportunities for audience engagement and discussion.
Outcomes with first-line obrixtamig plus standard of care in epNEC by DLL3 expression status: Phase Ib DAREON®-7 study
Aman Chauhan, MD, The University of California, San Francisco (UCSF)
A Phase 1 Trial of the Oncolytic Virus SVV-001 with Nivolumab and Ipilimumab in Patients with High Grade Neuroendocrine Neoplasms.
Aman Chauhan, MD, The University of California, San Francisco (UCSF)
Phase 1b Study of Zocilurtatug Pelitecan in Patients with Advanced Extra-Pulmonary Neuroendocrine Carcinomas
Amr Mohamed, MD, University Hospitals Seidman Cancer Center, Case Western Reserve University
A Phase I Study of Safety, Immunogenicity, and Preliminary Clinical Activity of the Survivin Long Peptide Vaccine (SurVaxM) in Patients with Metastatic Neuroendocrine Neoplasm
Jasmeet Kaur, MD, FACP, Roswell Park Comprehensive Cancer Center
Clinical Profile of Brain Metastases in Lung and High-Grade Neuroendocrine Neoplasms
Joseph Watts, B.S., University of Nevada, Reno, Renown Health
Featured Abstracts II: Emerging Strategies in High-Grade and Advanced NENs
Moderator: Po H. Ear, PhD, Associate Professor, Dept of Hematology & Medical Oncology, Winship Cancer Institute, Emory University School of Medicine
10:25 am – 11:25 pm
Advancing care for patients with rare cancers requires innovation, collaboration, and resilient leadership. This multidisciplinary panel explores the opportunities and challenges of building successful NET programs, advancing research, supporting early-career professionals, and sustaining a rewarding career in the field. Join an interactive discussion with experts representing diverse disciplines and perspectives from across the NET community.
Discussion Topics
-
Basic Science Development in NETs (Funding, Resources, etc.)
-
Building a Successful NET Program
-
Burnout and Professional Well-Being in NET Care
-
Early Career Development
-
Audience Q&A
Panelists
Rachael Guenter, PhD. Assistant Professor, The University of Alabama at Birmingham
Jonathan Loree, BMSc, MS, MD, FRCPC, Associate Professor of Medicine, BC Cancer – Vancouver
Betzaira Childers, MD, Assistant Member, Gastrointestinal Oncology Program, Moffitt Cancer Center
Daniel Bulzico, MD, PhD, MSc, Leader of the Endocrine Chapter of the Brazilian Neuroendocrine Tumor Expert Working Group, Section of Nuclear Medicine Radiopharmaceutical Therapies for Neuroendocrine Tumors, The Brazilian National Cancer Institute, Rio de Janeiro, Brazil
Tiffany Valone, PA-C, Supervisor of Advanced Practice Professionals, Moffitt Cancer Center
NET MED 4: Challenges in Rare Cancer
Moderator: Pamela L. Kunz, MD, Professor of Internal Medicine, Yale School of Medicine; Director, Center for Gastrointestinal Cancers, Smilow Cancer Hospital and Yale Cancer Center
11:25 am – 11:45 am
Break
2:30 pm – 3:30 pm
Presented in collaboration with the Society of Interventional Oncology (SIO), this collaborative session brings together experts in interventional radiology and gastroenterology to examine minimally invasive approaches to managing NET-related complications.
Portomesenteric and Caval Venous Occlusion
Nishita Kothary, MD, Professor of Radiology (Interventional Radiology), Stanford University
Enteric and Pancreatobiliary NET Complications: IR Approach
Erica S. Alexander, MD, Assistant Attending Radiologist, Memorial Sloan Kettering Cancer Center
Enteric and Pancreatobiliary Complications: GI Approach
Phillip S. Ge, MD, FASGE, Associate Professor, The University of Texas MD Anderson Cancer Center
Treatment of Cancer-Related Pain
Stephen J. Hunt, MTR, MD, PhD, FSIR, Associate Professor of Radiology, Hospital of the University of Pennsylvania; Co-Director, Penn Image-Guided Interventions Lab (PIGILab)
[Audience Discussion / Q&A]
Joint NANETS/SIOÂ Session: Interventional Procedures for NET-Related Complications
Moderator: Nicholas Fidelman, MD, FSIR, Professor of Radiology and Biomedical Imaging, University of California San Francisco
12:30 pm – 1:30 pm
Satellite Symposium: An Exelixis Product for the Clinical Management of Neuroendocrine Tumors
Mark Lewis, MD, Director, Gastrointestinal Oncology, Intermountain Health
Presented by Exelixis.Â
1:30 pm – 2:30 pm
NETCast Live Recordings
Be part of the conversation as NETCast, the official NANETS podcast, records live from the symposium. Attendees are invited to observe engaging discussions with faculty and special guests exploring timely topics in neuroendocrine tumor care.
Friday, November 6, 2026
8:00am – 9:00 am
Leadership in Practice: Navigating Your Career in NET Care
Join early-career physicians, trainees, and established leaders for an interactive breakfast focused on career development in neuroendocrine tumor care. Through candid conversation and shared experiences, attendees will gain practical insights on mentorship, leadership, professional growth, and building a successful multidisciplinary career while expanding their professional network.
11:45 am – 12:25 pm
Curated by the NANETS Scientific Review Committee, this featured session highlights emerging research and scientific breakthroughs with the potential to shape the future of neuroendocrine tumor care. Expert faculty will present and discuss innovative discoveries, novel approaches, and timely developments selected for their scientific significance and potential clinical impact. The session concludes with audience discussion.
Targeting the Epigenetic Landscape of GEP-NETs: Menin-MLL Inhibition as an Emerging Therapeutic Strategy
Suzann Duan, PhD, Assistant Professor, Â UC Irvine School of Pharmacy & Pharmaceutical Sciences; 2025 Basic/Translational Science Investigator (BTSI) Award Recipiant
Beyond Disease Stabilization: Exploiting Cell-Death Vulnerabilities in Gastroenteropancreatic Neuroendocrine Tumours
Iacovos Michael, PhD, Scientist, Sunnybrook Research Institute; Assistant Professor, University of Toronto; 2023 Basic/Translational Science Investigator (BTSI) Award Recipiant
Cutting Edge Research
Moderator: Julie Hallet, MD, MSc, FRCSC, Associate Professor, Department of Surgery, University of Toronto
1:45 pm – 2:30 pm
Patient Leaders Connect Meeting
A dedicated forum for NANETS Patient Advocacy Organization Members to connect with NANETS leadership and one another. Together, participants will discuss the evolving landscape of patient care and advocacy, share organizational priorities, and identify opportunities to strengthen partnerships in support of the NET community.
3:35 pm – 4:50 pm
Conclude the symposium's featured oral abstract presentations with another outstanding selection of research chosen from the highest-rated abstract submissions. This session showcases innovative scientific discoveries, clinical investigations, and emerging data that continue to advance the field of neuroendocrine tumor care, followed by audience discussion.
Epigenetic MTAP Loss Expands the Therapeutic Window of PRMT5 Inhibition in Gastroenteropancreatic Neuroendocrine Tumors
Danping Niu, Ph.D., The University of Texas MD Anderson Cancer Center
Integrated Bulk and Single-Cell Transcriptomics Identify Liver-Adaptive Tumor States in Metastatic siNET
Samira Sadowski, MD, Lasker Clinical Research Scholar, Surgical Oncology Program, NIH
Initial Cellular Characterization and Therapeutic Targeting of the Alternative Lengthening of Telomeres Phenotype in PNETs: Role of Telomeric Replication Stress
James Madigan, Ph.D., National Cancer Institute, NIH
NETest2.0® Accurately Detects Active Disease and Monitors Recurrence in Neuroendocrine Tumors: Results from the RegisterNET Registry
Mark Kidd, Ph.D., Wren Laboratories
Tumor Microenvironment Remodeling Mediates Resistance to 177Lu-DOTATATE in Metastatic Well-Differentiated Neuroendocrine Tumors
Rahil Abbu, MS, CCRP, University of Chicago
Featured Oral Abstracts III:Â Decoding NET Biology: From Mechanisms to Clinical Translation
Moderator: Namrata Vijayvergia, MD, Section Chief, Gastrointestinal Medical Oncology; Associate Professor, Department of Hematology/Oncology; Medical Director, Medical Oncology, Fox Chase Cancer Center
5:15 pm – 6:15 pm
Poster Session & Guided Poster Tours
Connect with researchers and colleagues while exploring the symposium's accepted poster presentations. Attendees are invited to enjoy refreshments, network with authors, and participate in curated faculty-led poster tours highlighting notable scientific discoveries and emerging research.
1:30 pm – 2:30 pm
NETworking Break
Take advantage of this intentionally scheduled break to recharge in the way that best suits you. Browse the Poster Hall, meet with industry partners, connect with colleagues, catch up on email, or enjoy some fresh air with a walk through the scenic grounds of the JW Marriott Las Vegas Resort & Spa.